UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under The Securities Exchange Act of 1934
(Amendment No. 1)*
SRI Surgical Express Inc.
-------------------------
(Name of Issuer)
Common Stock, Par Value $0.001
------------------------------
(Title of Class of Securities)
78464W104
---------
(CUSIP Number)
December 31, 2002
-----------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
[X] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 6 Pages
------------------- -----------------
CUSIP No. 78464W104 13G Page 2 of 6 Pages
------------------- -----------------
---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
F&C MANAGEMENT LIMITED
---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
---------- ---------------------------------------------------------------------
3 SEC USE ONLY
---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United Kingdom
-------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
456,800
NUMBER OF ------ ----------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
EACH ------ ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 456,800
------ ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
456,800
---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS) [ ]
---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.15%
---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IA, CO
---------- ---------------------------------------------------------------------
Item 1(a): Name of Issuer:
---------- ---------------
SRI Surgical Express Inc.
Item 1(b): Address of Issuer's Principal Executive Offices:
---------- ------------------------------------------------
12425 Racetrack Road
Tampa, FL 33626
Item 2(a) Name of Person Filing
--------- ---------------------
F&C Management Limited ("F&C Limited")
Item 2(b): Address of Principal Business Office:
---------- -------------------------------------
The address of the principal business office F&C Limited is
Exchange House, Primrose Street, London EC2A 2NY, England.
Item 2(c): Citizenship:
---------- ------------
F&C Limited is a corporation organized under the laws of the
United Kingdom.
Item 2(d): Title of Class of Securities:
---------- -----------------------------
Common Stock, par value $0.001 per share ("Common Stock").
Item 2(e): CUSIP Number:
---------- -------------
78464W104
Item 3: If this statement is filed pursuant to ss.ss. 240.13d-1(b)
------- or 240.13d-2(b) or (c), check whether the person filing
is a:
(e) [X] An investment adviser in accordance with ss.
240.13d-1(b)(1)(ii)(E).
Item 4: Ownership:
------- ----------
(a) Amount beneficially owned 456,800
(b) Percent of class: 7.15%
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote: 456,800
(ii) Shared power to vote or to direct the vote: 0
(iii) Sole power to dispose or to direct the
disposition of: 456,800
(iv) Shared power to dispose or to direct the
disposition of: 0
Page 4 of 6 Pages
Item 5: Ownership of Five Percent or Less of a Class:
------- ---------------------------------------------
If this statement is being filed to report the fact that as
of the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of
securities, check the following [ ].
Item 6: Ownership of More than Five Percent on Behalf of Another
------- --------------------------------------------------------
Person:
-------
Dividends received from, and proceeds from the sale of,
Common Stock, if any, by F&C Limited are allocated by F&C
Limited to the applicable accounts of its clients and are
distributed or retained in accordance with F&C Limited's
investment management agreements with those clients.
Item 7: Identification and Classification of the Subsidiary Which
------- ---------------------------------------------------------
Acquired the Security Being Reported on By the Parent
-----------------------------------------------------
Holding Company:
----------------
Not Applicable.
Item 8: Identification and Classification of Members of the Group:
------ ----------------------------------------------------------
Not Applicable.
Item 9: Notice of Dissolution of Group:
------- -------------------------------
Not Applicable.
Item 10: Certification:
-------- --------------
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired
and are held in the ordinary course of business and were not
acquired and are not held for the purpose of or with the
effect of changing or influencing the control of the issuer
of the securities and were not acquired and are not held in
connection with or as a participant in any transaction
having that purpose or effect.
Page 5 of 6 Pages
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: February 11, 2003
F&C MANAGEMENT LIMITED
By: /s/ Peter Cole
------------------------------
Peter Cole
Executive Director